About University of North Carolina Center for Inflammatory Bowel Disease
Clinical Trials at University of North Carolina Center for Inflammatory Bowel Disease
During the past decade, University of North Carolina Center for Inflammatory Bowel Disease conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at University of North Carolina Center for Inflammatory Bowel Disease
According to Clinical.Site data, the most researched conditions in "University of North Carolina Center for Inflammatory Bowel Disease" are
"Ulcerative Colitis" (2 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "University of North Carolina Center for Inflammatory Bowel Disease" in a lesser frequency.
Clinical Trials Intervention Types at University of North Carolina Center for Inflammatory Bowel Disease
Most popular intervention types in "University of North Carolina Center for Inflammatory Bowel Disease" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Mirikizumab" (2 trials), "Mirikizumab IV" (1 trials), "Mirikizumab SC" (1 trials) and "Placebo SC" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University of North Carolina Center for Inflammatory Bowel Disease
The vast majority of trials in "University of North Carolina Center for Inflammatory Bowel Disease" are
3 trials for "All" genders.
Clinical Trials Status at University of North Carolina Center for Inflammatory Bowel Disease
Currently, there are NaN active trials in "University of North Carolina Center for Inflammatory Bowel Disease".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in University of North Carolina Center for Inflammatory Bowel Disease,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in University of North Carolina Center for Inflammatory Bowel Disease, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".